Prostate cancer is the second leading cause of death in American men. Understanding the factors that influence patient outcomes is critical for improving treatment and survival rates.
May 8, 2023
0
8
Prostate cancer frequently metastasizes to the bone and is incurable. Moffitt Cancer Center researchers are working to identify new treatment options for this subset of patients. In a new article published today in Science ...
May 3, 2023
0
33
Cancer is an evolutionary disease. The same forces that turned dinosaurs into birds turn normal cells into cancer: genetic mutations and traits that confer a survival advantage.
May 2, 2023
0
6
Transgender women keep their prostates even after gender-affirming surgery, but the extent to which they remain at risk of prostate cancer has been unclear.
Apr 29, 2023
2
73
Over the decades, scientists have revealed many strategies our cells use to keep normal cells from becoming cancerous. Now, Fred Hutchinson Cancer Center scientists have discovered a completely new—and counterintuitive—emergency ...
Apr 20, 2023
0
61
Vitamin D deficiency could be the reason African American men experience more aggressive prostate cancer at a younger age compared with European American men, new research from Cedars-Sinai Cancer suggests. The multi-institutional ...
Apr 18, 2023
0
39
Olaparib (Lynparza), a targeted cancer drug, has been approved for hundreds of patients with certain breast cancers and prostate cancers in England.
Apr 11, 2023
0
22
Like the better-known prostate-specific antigen (PSA), prostate-specific membrane antigen (PSMA) is a biomarker that can tell physicians much about a patient's metastatic prostate cancer. PSMA is a protein on the cell surface ...
Apr 10, 2023
0
88
A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a phase 2 study led by investigators ...
Apr 6, 2023
0
7
When Professor Yan Liu was growing up in Changchun, China, her father wanted her to become a doctor like him. When she chose computer science, "I was a tiny bit disappointed," Xiwen Liu, a retired anesthesiologist, acknowledges.
Apr 5, 2023
0
4
